Research & Critiques
Thimerosal is an organic compound that is 49.6% ethyl mercury by weight. Developed as an antiseptic and antibacterial product, pharmaceutical companies began to use thimerosal in vaccines in the 1930s for the intended purpose of preventing bacterial contamination due to repeated needle punctures into multi-dose vials of vaccine. Below are links to abstracts from over 190 research studies detailing the effects of including thimerosal in vaccines.
Qvarnstrom 2003 – Determination of Methylmercury, Ethylmercury, and Inorganic Mercury in Mouse Tissues, Following Administration of Thimerosal, by Species-Specific Isotope Dilution GD-Inductively Coupled Plasma-MS
Secor 2011 – Novel Lipid-Soluble Thiol-Redox Antioxidant and Heavy Metal Chelator, N,N’bis(2-Mercaptoethyl)Isopthalamide (NBMI) and Phospholipase D-Specific Inhibitor, 5-Fluoro-2-Indolyl Des-Chlorohalopemide (FIPE) Attenuate Mercury-Induced Lipid Signaling Leading to Protection Against Cytotoxicity in Aortic Endothelial Cells